DE60317070D1 - Verfahren zur diagnose von multipler sklerose - Google Patents

Verfahren zur diagnose von multipler sklerose

Info

Publication number
DE60317070D1
DE60317070D1 DE60317070T DE60317070T DE60317070D1 DE 60317070 D1 DE60317070 D1 DE 60317070D1 DE 60317070 T DE60317070 T DE 60317070T DE 60317070 T DE60317070 T DE 60317070T DE 60317070 D1 DE60317070 D1 DE 60317070D1
Authority
DE
Germany
Prior art keywords
multiple sclerosis
diagnosis
diagnosing multiple
glycans
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60317070T
Other languages
English (en)
Other versions
DE60317070T2 (de
Inventor
Nir Dotan
Avinoam Dukler
Mikael Schwarz
Ari Gargir
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycominds Ltd
Original Assignee
Glycominds Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd filed Critical Glycominds Ltd
Application granted granted Critical
Publication of DE60317070D1 publication Critical patent/DE60317070D1/de
Publication of DE60317070T2 publication Critical patent/DE60317070T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Testing Of Engines (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Heat Treatment Of Steel (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60317070T 2002-08-02 2003-08-04 Verfahren zur diagnose von multipler sklerose Expired - Lifetime DE60317070T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US40091402P 2002-08-02 2002-08-02
US400914P 2002-08-02
US44707603P 2003-02-13 2003-02-13
US447076P 2003-02-13
US46298403P 2003-04-15 2003-04-15
US462984P 2003-04-15
US47323103P 2003-05-23 2003-05-23
US473231P 2003-05-23
PCT/IB2003/003878 WO2004015420A1 (en) 2002-08-02 2003-08-04 Method for diagnosing multiple sclerosis

Publications (2)

Publication Number Publication Date
DE60317070D1 true DE60317070D1 (de) 2007-12-06
DE60317070T2 DE60317070T2 (de) 2008-07-24

Family

ID=31721743

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60317070T Expired - Lifetime DE60317070T2 (de) 2002-08-02 2003-08-04 Verfahren zur diagnose von multipler sklerose

Country Status (18)

Country Link
US (2) US7537900B2 (de)
EP (1) EP1529216B1 (de)
JP (2) JP4721703B2 (de)
AT (1) ATE376672T1 (de)
AU (1) AU2003263409B2 (de)
BR (1) BR0313194A (de)
CA (1) CA2494422A1 (de)
CY (1) CY1107859T1 (de)
DE (1) DE60317070T2 (de)
DK (1) DK1529216T3 (de)
ES (1) ES2297248T3 (de)
IL (1) IL166539A (de)
MX (1) MXPA05001270A (de)
NO (1) NO20051024L (de)
NZ (1) NZ585114A (de)
PL (1) PL210512B1 (de)
PT (1) PT1529216E (de)
WO (1) WO2004015420A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4721703B2 (ja) * 2002-08-02 2011-07-13 グリコマインズ リミテッド 多発性硬化症を診断するための方法
WO2005054853A2 (en) * 2003-12-03 2005-06-16 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
US7592150B2 (en) 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
WO2006002382A2 (en) * 2004-06-24 2006-01-05 The Scripps Research Institute Arrays with cleavable linkers
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US8216791B2 (en) 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
EP1929297B1 (de) * 2005-09-29 2012-11-21 Caprion Proteomics USA, LLC Biomarker für multiple sklerose und verwendungsverfahren dafür
US20100203569A1 (en) * 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
US20120190581A1 (en) * 2009-08-25 2012-07-26 The Johns Hopkins University Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune Diseases
JP6502374B2 (ja) 2014-03-13 2019-04-17 ウニヴェルズィテート バーゼル ミエリン関連糖タンパク質に対するＩｇＭ抗体に結合する炭水化物リガンド
WO2016026143A1 (en) * 2014-08-22 2016-02-25 Huiru Wang Saccharide-based biomarkers and therapeutics
US10495646B2 (en) 2015-01-30 2019-12-03 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of MS disease course
WO2017046172A1 (en) 2015-09-16 2017-03-23 Universität Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
WO2018006051A1 (en) * 2016-07-01 2018-01-04 Dignity Health Diagnostic or predictor of relapsing remitting multiple sclerosis
WO2019195448A1 (en) * 2018-04-03 2019-10-10 Creatics Llc Methods for cancer detection by evaluation of glycan-binding patterns of immunoglobulins in gastrointestinal lavage fluid samples

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
JPH02161357A (ja) * 1988-12-15 1990-06-21 Tosoh Corp 免疫測定用材料の安定化方法
WO2000049412A1 (en) 1999-02-17 2000-08-24 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
IL150434A0 (en) * 2000-01-10 2002-12-01 Genospectra Inc Linear probe carrier
WO2002018950A1 (en) * 2000-08-28 2002-03-07 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
US20040241763A1 (en) * 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
JP4721703B2 (ja) * 2002-08-02 2011-07-13 グリコマインズ リミテッド 多発性硬化症を診断するための方法
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
US20100081160A1 (en) 2010-04-01
DK1529216T3 (da) 2008-02-25
DE60317070T2 (de) 2008-07-24
ES2297248T3 (es) 2008-05-01
WO2004015420A1 (en) 2004-02-19
IL166539A0 (en) 2006-01-15
BR0313194A (pt) 2005-07-12
CY1107859T1 (el) 2013-06-19
AU2003263409A1 (en) 2004-02-25
JP2009258138A (ja) 2009-11-05
JP4721703B2 (ja) 2011-07-13
PT1529216E (pt) 2008-01-30
WO2004015420A8 (en) 2004-09-10
NZ585114A (en) 2011-09-30
EP1529216B1 (de) 2007-10-24
PL210512B1 (pl) 2012-01-31
AU2003263409B2 (en) 2010-05-27
PL374869A1 (en) 2005-11-14
ATE376672T1 (de) 2007-11-15
US7537900B2 (en) 2009-05-26
NO20051024L (no) 2005-05-02
IL166539A (en) 2010-11-30
US20040077023A1 (en) 2004-04-22
JP2006501441A (ja) 2006-01-12
EP1529216A1 (de) 2005-05-11
WO2004015420B1 (en) 2004-04-29
CA2494422A1 (en) 2004-02-19
MXPA05001270A (es) 2005-08-03

Similar Documents

Publication Publication Date Title
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
DE602006019206D1 (de) Verfahren zur diagnose von multipler sklerose
ATE427695T1 (de) Stoffwechseluberwachung, verfahren und gerat zur anzeige eines gesundheitsbezogenen zustands einer person
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
WO2004113912A8 (en) System and method for determining a temperature during analysis of biological fluid
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
NO339224B1 (no) Bedrede immunprøvemetoder
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
ATE469351T1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE350659T1 (de) Verfahren zur identifizierung von proben eines säugetiers als auch ein kit zur durchführung des verfahrens
DE60317484D1 (de) Verfahren und vorrichtung zur vorhersage von kardiovaskulären ereignissen
ATE485060T1 (de) Verfahren zur diagnose von infektionskrankheiten
ATE514951T1 (de) Verfahren zur prüfung eines mehrkanaligen elements zur blutanalyse
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
ATE437372T1 (de) Verfahren zur messung von proinsulin und c-peptid sowie kit dafür
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
ATE403877T1 (de) Verfahren zur untersuchung der aktivität von ionenkanälen
ATE223055T1 (de) Verfahren zur diagnose von chlamydia in einer biologischen extrazellulären flüssigkeit
DE50201173D1 (de) Verfahren zur analyse einer biologischen probe
DE602007008581D1 (de) Verfahren zur bestimmung des antigengehalts in einer probe unter verwendung eines immunhistochemischen doppelnachweises
DE602004026869D1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
ATE246809T1 (de) Verfahren zur bestimmung der alkoholkonsumrate
ATE526582T1 (de) Generisches verfahren für latex- agglutinationstests

Legal Events

Date Code Title Description
8364 No opposition during term of opposition